ArticleScientific reports2024

Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation.

Rashin Mohseni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.